Coronavirus Stocks

Below you will find a list of companies that have had the highest percentage gains and losses since coronavirus (COVID-19) became a major issue in the United States, which was approximately March 1st, 2020. Learn more.

Show:
CompanyYesterday's ClosePrice on March 1st, 2020Price ChangeConsensus RatingPrice TargetIndicator(s)
MicroVision logo
MVIS
MicroVision
$17.35$0.25+6,725.3%HoldGap Down
GameStop logo
GME
GameStop
$200.27$3.60+5,463.1%Hold$11.93Gap Down
Riot Blockchain logo
RIOT
Riot Blockchain
$60.65$1.14+5,220.2%Buy$28.00Upcoming Earnings
Marathon Patent Group logo
MARA
Marathon Patent Group
$43.05$0.86+4,907.6%Buy$50.00
Axon Enterprise logo
AXON
Axon Enterprise
$144.75$2.93+4,840.3%Buy$183.50
ContextLogic logo
WISH
ContextLogic
$17.86$0.47+3,740.9%Buy$24.25
Oasis Petroleum logo
OAS
Oasis Petroleum
$58.34$1.64+3,468.2%Hold$1.33News Coverage
Kopin logo
KOPN
Kopin
$11.14$0.32+3,425.3%Buy$3.00Gap Down
Aclaris Therapeutics logo
ACRS
Aclaris Therapeutics
$26.79$1.14+2,250.0%N/AGap Down
Ocugen logo
OCGN
Ocugen
$8.92$0.45+1,882.2%Buy$4.80Earnings Announcement

Expert: “There is Still Time to Profit from the Cannabis Boom” (Ad)

Medical cannabis stocks have delivered solid gains over the last 3 years. In fact, since 2017, 21 medical cannabis stocks have soared by more than 1,000%.

Yet, with medical cannabis sales expected to triple by 2026, the market still offers significant profit potential.

Don't Miss This One
Vuzix logo
VUZI
Vuzix
$28.81$1.58+1,723.5%Buy$21.50Analyst Report
Whiting Petroleum logo
WLL
Whiting Petroleum
$33.29$1.85+1,699.5%Hold$33.67
Blink Charging logo
BLNK
Blink Charging
$38.24$2.27+1,584.6%Buy$21.50Upcoming Earnings
Gap Down
Callon Petroleum logo
CPE
Callon Petroleum
$37.58$2.27+1,555.5%Hold$11.84Gap Up
Novavax logo
NVAX
Novavax
$228.25$16.00+1,326.6%Buy$229.64
Digital Turbine logo
APPS
Digital Turbine
$81.00$6.13+1,221.4%Buy$67.79Analyst Report
News Coverage
Gap Down
C3.ai logo
AI
C3.ai
$74.52$5.66+1,216.6%Hold$141.33
Overstock.com logo
OSTK
Overstock.com
$76.83$6.46+1,089.3%Buy$113.17
Silvergate Capital logo
SI
Silvergate Capital
$160.36$14.74+987.9%Buy$98.17
eXp World logo
EXPI
eXp World
$51.73$4.78+982.2%Buy$67.00
Danaos logo
DAC
Danaos
$53.35$5.04+958.5%Buy$33.13Analyst Revision
News Coverage
Gap Down
Piedmont Lithium logo
PLL
Piedmont Lithium
$78.94$7.50+952.5%Buy$59.50
NIO logo
NIO
NIO
$43.35$4.13+949.6%Buy$49.94
Cassava Sciences logo
SAVA
Cassava Sciences
$57.77$5.61+929.8%Buy$35.33Upcoming Earnings
Analyst Report
Jumia Technologies logo
JMIA
Jumia Technologies
$42.14$4.11+925.3%Hold$19.67
GrowGeneration logo
GRWG
GrowGeneration
$54.78$5.53+890.6%Buy$49.57Upcoming Earnings
News Coverage
Gap Down
Five Prime Therapeutics logo
FPRX
Five Prime Therapeutics
$37.92$3.83+890.1%Hold$30.71
Pacific Biosciences of California logo
PACB
Pacific Biosciences of California
$33.43$3.40+883.2%Buy$43.50
VMware logo
VMW
VMware
$145.98$15.00+873.2%Buy$169.84
Celldex Therapeutics logo
CLDX
Celldex Therapeutics
$25.09$2.63+854.0%Buy$35.50Upcoming Earnings
Tupperware Brands logo
TUP
Tupperware Brands
$26.68$2.85+836.1%Hold$32.00
Bionano Genomics logo
BNGO
Bionano Genomics
$9.03$0.99+809.3%Buy$7.81News Coverage
Gap Down
Plug Power logo
PLUG
Plug Power
$38.28$4.34+782.0%Buy$53.57Analyst Report
Cambium Networks logo
CMBM
Cambium Networks
$49.48$6.25+691.7%Buy$36.13Gap Down
Celsius logo
CELH
Celsius
$46.23$5.91+682.2%Buy$36.25Gap Down
FuelCell Energy logo
FCEL
FuelCell Energy
$14.97$1.95+667.7%Hold$8.50
Fiverr International logo
FVRR
Fiverr International
$224.93$31.48+614.5%Buy$222.17
Fulgent Genetics logo
FLGT
Fulgent Genetics
$105.96$14.84+614.0%Hold$74.40
Caesars Entertainment logo
CZR
Caesars Entertainment
$89.32$12.71+602.8%Buy$77.16
Clean Energy Fuels logo
CLNE
Clean Energy Fuels
$15.66$2.26+592.9%Buy$18.67
GenMark Diagnostics logo
GNMK
GenMark Diagnostics
$24.04$3.49+588.8%Hold$22.01Analyst Report
Gevo logo
GEVO
Gevo
$10.01$1.46+585.6%Buy$17.00Earnings Announcement
Seres Therapeutics logo
MCRB
Seres Therapeutics
$21.45$3.14+583.1%Buy$38.17
NantKwest logo
NK
NantKwest
$32.49$4.84+571.3%Buy$18.00Upcoming Earnings
High Trading Volume
At Home Group logo
HOME
At Home Group
$33.08$5.00+561.6%Hold$20.94
Amyris logo
AMRS
Amyris
$20.82$3.19+553.7%Buy$17.87Gap Down
Antero Resources logo
AR
Antero Resources
$9.81$1.60+513.1%Hold$7.08
Daqo New Energy logo
DQ
Daqo New Energy
$79.23$13.11+504.2%Buy$57.60Gap Down
SunOpta logo
STKL
SunOpta
$15.65$2.70+479.6%Buy$17.00
MicroStrategy logo
MSTR
MicroStrategy
$777.04$135.16+474.9%Sell$276.00

Cannabis Super Strain Could Destroy Competitors (Ad)

Its breakthrough super strain of hemp could lead an Oregon agribusiness to blow up the North American cannabis market. That’s good news for people who can move now to become one of the company’s earliest investors. The new super strain of hemp has 3X more CBD per bud than competitors’. The Oregon grower has cracked the cannabis yield code.

Discover What Could Be 2021’s #1 Cannabis Stock
Owens & Minor logo
OMI
Owens & Minor
$38.47$6.83+463.3%Hold$25.50
Moderna logo
MRNA
Moderna
$143.74$25.93+454.3%Hold$149.65Analyst Report
United Natural Foods logo
UNFI
United Natural Foods
$35.06$6.47+441.9%Hold$25.67
Farfetch logo
FTCH
Farfetch
$59.88$11.17+436.1%Buy$55.08
Workhorse Group logo
WKHS
Workhorse Group
$16.12$3.02+434.7%Hold$19.00
Wayfair logo
W
Wayfair
$335.36$63.21+430.5%Hold$289.87
Aphria logo
APHA
Aphria
$19.34$3.66+428.4%Buy$17.79Analyst Upgrade
Upwork logo
UPWK
Upwork
$45.47$8.67+424.8%Buy$62.00Insider Selling
Calix logo
CALX
Calix
$45.93$9.00+410.3%Buy$34.00
The Michaels Companies logo
MIK
The Michaels Companies
$21.85$4.29+409.3%Hold$15.50
Tesla logo
TSLA
Tesla
$654.87$132.87+392.9%Hold$324.92Gap Down
Intellia Therapeutics logo
NTLA
Intellia Therapeutics
$65.70$13.35+392.1%Buy$56.62Analyst Report
DermTech logo
DMTK
DermTech
$57.60$11.97+381.2%Buy$56.75
SEA logo
SE
SEA
$214.90$45.06+376.9%Buy$204.92
Westport Fuel Systems logo
WPRT
Westport Fuel Systems
$8.85$1.87+374.5%Buy$13.00Analyst Report
Cerence logo
CRNC
Cerence
$102.59$21.71+372.5%Buy$106.67
Niu Technologies logo
NIU
Niu Technologies
$40.07$8.52+370.3%Buy$36.14
Vista Outdoor logo
VSTO
Vista Outdoor
$34.50$7.35+369.4%Buy$37.75
500.com logo
WBAI
500.com
$24.90$5.39+362.0%N/AGap Down
SiTime logo
SITM
SiTime
$102.90$22.66+354.1%Buy$113.00
Big Lots logo
BIG
Big Lots
$70.64$15.81+346.8%Hold$56.18
Scholar Rock logo
SRRK
Scholar Rock
$62.55$14.11+343.3%Buy$61.60
BioCryst Pharmaceuticals logo
BCRX
BioCryst Pharmaceuticals
$13.24$3.00+341.3%Buy$11.78News Coverage
Gap Down
Sorrento Therapeutics logo
SRNE
Sorrento Therapeutics
$9.56$2.17+340.6%Buy$28.75
Ocular Therapeutix logo
OCUL
Ocular Therapeutix
$20.67$4.71+339.3%Buy$24.80
XPEL logo
XPEL
XPEL
$56.07$12.91+334.3%Buy$64.50
Twist Bioscience logo
TWST
Twist Bioscience
$130.29$30.62+325.5%Hold$133.33
Bilibili logo
BILI
Bilibili
$108.86$25.68+323.9%Buy$55.86
Live Oak Bancshares logo
LOB
Live Oak Bancshares
$64.51$15.37+319.7%Buy$47.00
EHang logo
EH
EHang
$46.31$11.05+319.1%Buy$14.00
Beam Therapeutics logo
BEAM
Beam Therapeutics
$92.89$22.49+313.0%Buy$96.00
Beam Therapeutics logo
BEAM
Beam Therapeutics
$92.89$22.49+313.0%Buy$96.00
Snap logo
SNAP
Snap
$58.36$14.17+311.9%Buy$65.21Analyst Downgrade
Insider Selling
News Coverage
Gap Up
Peloton Interactive logo
PTON
Peloton Interactive
$108.31$26.69+305.8%Buy$150.39
Protagonist Therapeutics logo
PTGX
Protagonist Therapeutics
$31.15$7.80+299.4%Buy$38.00
Penn National Gaming logo
PENN
Penn National Gaming
$117.37$29.57+296.9%Buy$94.16
Pinduoduo logo
PDD
Pinduoduo
$141.80$35.78+296.3%Buy$140.53Earnings Announcement
Analyst Upgrade
Analyst Revision
ViacomCBS logo
VIAC
ViacomCBS
$97.35$24.61+295.6%Hold$44.32Analyst Report
TG Therapeutics logo
TGTX
TG Therapeutics
$49.10$12.55+291.2%Buy$64.00
Anavex Life Sciences logo
AVXL
Anavex Life Sciences
$14.89$3.81+290.8%Buy$17.60
Lithium Americas logo
LAC
Lithium Americas
$15.97$4.09+290.5%Buy$19.54Gap Down
Hibbett Sports logo
HIBB
Hibbett Sports
$76.04$19.52+289.5%Hold$37.75
Vericel logo
VCEL
Vericel
$59.48$15.43+285.5%Buy$49.00
Glaukos logo
GKOS
Glaukos
$88.43$22.99+284.6%Hold$58.40
Range Resources logo
RRC
Range Resources
$10.49$2.77+278.7%Hold$8.83
Pinterest logo
PINS
Pinterest
$73.01$19.50+274.4%Buy$75.85Analyst Downgrade
Etsy logo
ETSY
Etsy
$215.41$57.81+272.6%Buy$197.70
SunPower logo
SPWR
SunPower
$31.86$8.57+271.8%Hold$29.64Analyst Downgrade
Gap Down
New Fortress Energy logo
NFE
New Fortress Energy
$52.00$14.05+270.1%Buy$43.15Analyst Upgrade
Kraton logo
KRA
Kraton
$37.20$10.12+267.6%Hold$21.20
CSV / Excel Export To export this table to CSV or Excel, upgrade to MarketBeat All Access.


(Ad)

This could be the window of opportunity you've been seeking for.

The market contagion stemming from the spread of coronavirus has prompted companies to pre-emptively cut top and bottom-line forecasts citing supply chain disruptions and demand uncertainties. The S&P 500 (NYSEARCA: SPY) has descended into correction territory stoking fears of an impending bear market. The Federal Reserve implemented an emergency 50-basis point rate cut on March 2, 2020, to stave off coronavirus impact on the economy. Further rate cuts of at least another 50-basis points are anticipated in their meeting later this month. The yield on 10-year Treasuries sank to all-time lows below 0.7% bolstering fears of a global recession. Investors seeking portfolio protection during this tumultuous period of stock market uncertainty should take a closer look at these three stocks.

CoreLogic Inc. (NYSE: CLGX)

The dominant real estate, mortgage, and underwriting data analytics platform provider CoreLogic, Inc. (NYSE: CLGX)is a direct beneficiary of the spike in mortgage refi activity. Revenues grew six-percent YoY in their Q4 2019 earnings report beating consensus analyst EPS estimates by 0.07-per share coming in at 0.77-per share. Core mortgage and real estate solutions were the primary growth driver. This was prior to the coronavirus epidemic. Falling yields have materialized as a consequence of the economic turmoil unleashed by the spread of COVID-19. With the anticipation of more rate cuts to follow, mortgage lenders are experiencing a surge in mortgage refinancing activity. For example, a 15-year fixed rate of 3.12-percent just five years ago can be refinanced as a 10-year loan at 2.5-percent resulting in hundreds of dollars in monthly savings. While money center banks are seeing upticks on the mortgage side, that’s being offset by narrowing margins. For this reason, investors can sidestep the financials and consider the platform provider.

Utilizing the rifle charts, CLGX is one of the rare stocks with a double bullish monthly pup formation composed of a moving average (MA) pup breakout and a stochastic mini pup breakout. This is made possible by the resilient support on the rising 5-period MA at 45.48. The trajectory targets the upper monthly Bollinger Bands (BBs) at the 55.55 Fibonacci (fib) level.

Catasys (CATS)

In an era of healthcare cost-cutting initiatives, behavioral and mental health analytics, network and treatment platform provider Catasys, Inc. (NASDAQ: CATS) has a unique business model that optimizes efficiencies for insurers, providers and patients. Utilizing big data predictive analytics, CATS identifies health plan members that meet criteria for their proprietary OnTrak solution. CATS contracts with most of the nation’s largest health insurers to transition the most at risk and costliest patients who also suffer from behavioral, mental and/or substance abuse. Discreetly enrolling them in the 52-week OnTrak solution, patients utilize telemedicine and behavioral therapy to improve health as insurers see a 50-percent drop in healthcare costs, which CATS takes a percentage of. The model is designed to trim healthcare costs while improving patient care with the outcome and evidence-based treatment versus the traditional treatment center model which relies on higher healthcare costs from rising headcounts and longer “heads on beds” model. Revenues are improving but the company has yet to turn a profit. CATS is riding the healthcare cost efficiency and evidence-based treatment narrative which will continue to gain momentum, especially in an election year. CATS monthly chart has a potential monthly pup breakout which would target the 22.00 upper monthly BBs if the stochastic can cross back up.

Realty Income (O)  

Real estate investment trusts (REITs) tend to outperform benchmark indices during recessionary periods with stable dividends that can offset share depreciation. Realty Income (NYSE: O) is one of the most stable REITs with over 6,400 commercial properties throughout the U.S, U.K. and Puerto Rico. With a 98.6-percent occupancy rate, tenants include well-known household brands like Walgreens (NYSE: WBA) , Walmart (NYSE: WMT) , FedEx (NYSE: FDX) , 7-Eleven, Dollar Tree (NYSE: DLTR) and Dollar General (NYSE: DG). The company has distributed 595 consecutive months of dividends with 105 dividend increases since its NYSE listing in 1994. The company prides itself as a monthly dividend paying REIT currently yielding 3.70-percent on trailing 12-month basis. They also have a dividend reinvestment program (DRIP) for compounding gains and better dollar-cost averaging to take advantage of market downturns. Since O is a component of the SPY, there is a positive correlation with the trajectory of the benchmark S&P 500 index. Therefore, shares will still fall with the SPY. This one makes sense for investors with a long-term bullish outlook seeking steady monthly income at better than 10-year Treasury yields.

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257
MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement
Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.